Steven Wisniewski
Internal Medicine · Gaylord, MINPI 1104851658
Payments from drug & device makers
Across 131 payments — averaging $16.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$342
- Boehringer Ingelheim$281
- Pfizer$272
- AstraZeneca$189
- Novo Nordisk$185
- Novartis$153
- plus $748 from 17 others
What the payments were for
- Food & beverage$2,15699%
- Education$151%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 18 | $342 |
| Boehringer Ingelheim | 14 | $281 |
| Pfizer | 21 | $272 |
| AstraZeneca(2 entities) | 12 | $189 |
| Novo Nordisk | 11 | $185 |
| Novartis | 10 | $153 |
| GSK | 8 | $124 |
| Astellas Pharma US Inc | 5 | $73 |
| Amgen | 4 | $72 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $67 |
| Otsuka America Pharmaceutical, Inc. | 3 | $65 |
| Lilly USA, LLC | 4 | $55 |
| Johnson & Johnson | 4 | $50 |
| E.r. Squibb & Sons, L.L.C. | 3 | $45 |
| Bayer | 2 | $35 |
| Medtronic | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $22 |
| Merck | 1 | $20 |
| Exact Sciences | 1 | $17 |
| Electromed, Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $12 |
How this compares
$2,171 in reported general payments places this provider in the 80th percentile of 4,567 internal medicine providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 266 | $220,332 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 153 | $136,550 |
| JardianceEmpagliflozin | 67 | $80,422 |
| FarxigaDapagliflozin Propanediol | 81 | $75,219 |
| OzempicSemaglutide | 53 | $60,476 |
| MounjaroTirzepatide | 50 | $57,094 |
| TrulicityDulaglutide | 25 | $29,039 |
| JanuviaSitagliptin Phosphate | 24 | $22,923 |
| InvokanaCanagliflozin | 14 | $22,813 |
| MyrbetriqMirabegron | 38 | $21,444 |
| XareltoRivaroxaban | 19 | $17,098 |
| Atorvastatin Calcium | 720 | $11,128 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 78 | $10,055 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $8,782 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $8,377 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $272 | $220,332266 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $124 | $153,710183 claims |
| Lilly USA, LLCMounjaro, Trulicity | $55 | $86,13375 claims |
| AstraZenecaFarxiga, Symbicort | $189 | $81,719102 claims |
| Boehringer IngelheimJardiance | $281 | $80,42267 claims |
| Novo NordiskOzempic | $185 | $60,47653 claims |
| Johnson & JohnsonInvokana, Xarelto | $50 | $39,91233 claims |
| MerckJanuvia | $20 | $22,92324 claims |
| Astellas Pharma US IncMyrbetriq | $73 | $21,44438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,567 internal medicine providers in Michigan.
Other internal medicine in Gaylord
- Ulka VaishampayanAnn Arbor$33.7M
- Jeffrey PottsBay City$14.7M
- Neil FraserTroy$14.3M
- Abdulhassan SaadDearborn$11.5M
- Leslie PelkeyGrand Rapids$8.5M
- Jay SandbergTroy$8.3M
- Ding WangDetroit$6.8M
- Dipenkumar ModiDetroit$4.1M
- Ahmed ArifFlint$4.1M
- Sudipto MukherjeeRoyal Oak$3.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.